🟢 Echo IQ is trading 14.56% up today after management outlined potential FDA clearance routes

Echo IQ is trading 14.56% up at A$0.59 after management said it believes there is a clear path toward FDA clearance for EchoSolv HF.

• FDA concerns appeared limited to statistical-analysis aspects rather than the software’s core technology.
• The company outlined potential appeals, ombudsman review, or a new 510(k) submission.
• The rebound follows a 50% September 9 decline after the initial FDA setback.